Hiroomi Tada - Mar 15, 2024 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Role
Chief Medical Officer
Signature
/s/ Ali D. Fawaz, Attorney-in-Fact
Stock symbol
TYRA
Transactions as of
Mar 15, 2024
Transactions value $
$12,947
Form type
4
Date filed
3/19/2024, 07:58 PM
Previous filing
Sep 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TYRA Common Stock Award $12.9K +1.97K +2.33% $6.58 86.4K Mar 15, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.